Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 204 of 1,261

  1. US 11607426

    Method of targeting oncolytic viruses to tumors

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  2. US 11607448

    Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  3. US 11607387

    Efficient aqueous encapsulation and controlled release of bioactive agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  4. US 11607412

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  5. US 11608354

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Theravance Biopharma R&D IP, LLC · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  6. US 11607435

    Probiotics Bifidobacteria strains

    PERFECT (CHINA) CO., LTD. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  7. US 11607462

    Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury

    Northwestern University · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  8. US 11607414

    Small molecule inhibitors of EGFR and PI3K

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  9. US 11607464

    Compositions and methods for the treatment and imaging of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  10. US 11608454

    High performance adhesives; methods of making; and use

    South China University of Technology · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  11. US 11608503

    RNA targeting of mutations via suppressor tRNAs and deaminases

    The Regents of the University of California · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  12. US 11607408

    Method of treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  13. US 11607456

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  14. US 11602568

    Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them

    The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  15. US 11602567

    Methods for modulating RNA splicing

    PTC THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  16. US 11602559

    HIV-1 Env fusion peptide immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  17. US 11602515

    Pharmaceutical compositions comprising dimethyl fumarate

    Almirall, S.A. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  18. US 11603364

    Acyl hydrazone derivative compounds for treating disease

    Alterity Therapeutics Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  19. US 11603519

    T-cell receptor

    Takeda Pharmaceutical Company Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  20. US 11603407

    Stable antibody formulation

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  21. US 11603408

    Methods for treating skin infection by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  22. US 11603351

    Carboxamides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  23. US 11602556

    Insulin mimotopes and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  24. US 11603365

    Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.